# In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule

> **NCT02916329** · NA · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Molecular Imaging

## Interventions

- **OTHER:** 68Ga-NODAGA-Ac-Cys-ZEGFR:1907

## Key facts

- **NCT ID:** NCT02916329
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2016-10
- **Final completion:** 2018-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02916329

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02916329, "In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02916329. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*